Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00131313
Status:
UNKNOWN
Last Update Posted:
2005-08-18
First Post:
2005-08-16
Brief Title:
Efficacy and Safety of Nipent Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia
Sponsor:
East Valley Hematology and Oncology Medical Group
Organization:
East Valley Hematology and Oncology Medical Group
Organization Data
Organization:
East Valley Hematology and Oncology Medical Group
Class:
OTHER
Study ID:
POI-02818
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
East Valley Hematology and Oncology Medical Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Astex Pharmaceuticals Inc | INDUSTRY |
| Mena Raul MD | INDIV |
| Pharmatech Oncology | INDUSTRY |